On the public citation graph

One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists

0 signed · 116 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1521-3757(19990614)111:12<1902::aid-ange1902>3.0.co;2-oopenalex-snapshot
Charakterisierung von Ligandenbindung durch Sättigungstransfer-Differenz-NMR-Spektroskopie
inferredcites →https://doi.org/10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-qopenalex-snapshot
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy
inferredcites →https://doi.org/10.1002/3527608761openalex-snapshot
Fragment‐based Approaches in Drug Discovery
inferredcites →https://doi.org/10.1002/ange.201202660openalex-snapshot
High‐Throughput Interrogation of Ligand Binding Mode Using a Fluorescence‐Based Assay
inferredcites →https://doi.org/10.1002/ange.201411206openalex-snapshot
Chamäleon‐artige Bindungsmodi in der Leitstrukturoptimierung: wechselnde Bindungsgeometrien bei Aspartylprotease‐Inhibitoren
inferredcites →https://doi.org/10.1002/anie.201202660openalex-snapshot
High‐Throughput Interrogation of Ligand Binding Mode Using a Fluorescence‐Based Assay
inferredcites →https://doi.org/10.1002/anie.201411206openalex-snapshot
Tracing Binding Modes in Hit‐to‐Lead Optimization: Chameleon‐Like Poses of Aspartic Protease Inhibitors
inferredcites →https://doi.org/10.1002/cmdc.201100490openalex-snapshot
Experimental and Computational Active Site Mapping as a Starting Point to Fragment‐Based Lead Discovery
inferredcites →https://doi.org/10.1007/978-1-59745-398-1_15openalex-snapshot
Nondenaturing Mass Spectrometry to Study Noncovalent Protein/Protein and Protein/Ligand Complexes: Technical Aspects and Application to the Determination of Binding Stoichiometries
inferredcites →https://doi.org/10.1007/s00216-008-2477-yopenalex-snapshot
Direct optical detection in fragment-based screening
inferredcites →https://doi.org/10.1007/s10822-009-9288-xopenalex-snapshot
Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology
inferredcites →https://doi.org/10.1016/0014-5793(84)81085-6openalex-snapshot
The active site of aspartic proteinases
inferredcites →https://doi.org/10.1016/b978-0-12-381274-2.00011-xopenalex-snapshot
Protein Thermal Shifts to Identify Low Molecular Weight Fragments
inferredcites →https://doi.org/10.1016/b978-0-12-381274-2.00012-1openalex-snapshot
HTS Reporter Displacement Assay for Fragment Screening and Fragment Evolution Toward Leads with Optimized Binding Kinetics, Binding Selectivity, and Thermodynamic Signature
inferredcites →https://doi.org/10.1016/j.ab.2004.04.031openalex-snapshot
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery
inferredcites →https://doi.org/10.1016/j.bbagen.2014.12.007openalex-snapshot
Thermodynamic signatures of fragment binding: Validation of direct versus displacement ITC titrations
inferredcites →https://doi.org/10.1016/j.cbpa.2007.07.010openalex-snapshot
Fragment-based screening using X-ray crystallography and NMR spectroscopy
inferredcites →https://doi.org/10.1016/j.coph.2009.04.009openalex-snapshot
Recent progress in fragment-based lead discovery
inferredcites →https://doi.org/10.1016/j.drudis.2007.08.005openalex-snapshot
Integration of fragment screening and library design
inferredcites →https://doi.org/10.1016/j.drudis.2009.04.007openalex-snapshot
From fragment to clinical candidate—a historical perspective
inferredcites →https://doi.org/10.1016/j.drudis.2009.07.013openalex-snapshot
NMR methods in fragment screening: theory and a comparison with other biophysical techniques
inferredcites →https://doi.org/10.1016/j.ymeth.2012.12.005openalex-snapshot
Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions
inferredcites →https://doi.org/10.1016/s1359-6446(03)02831-9openalex-snapshot
A ‘Rule of Three’ for fragment-based lead discovery?
inferredcites →https://doi.org/10.1016/s1359-6446(05)03511-7openalex-snapshot
Fragment-based lead discovery: leads by design
inferredcites →https://doi.org/10.1021/bi3005126openalex-snapshot
Fragment-Based Approaches in Drug Discovery and Chemical Biology
inferredcites →https://doi.org/10.1021/cb9003139openalex-snapshot
A Fragment-Based Approach to Identifying Ligands for Riboswitches
inferredcites →https://doi.org/10.1021/ja00016a069openalex-snapshot
Detection of noncovalent receptor-ligand complexes by mass spectrometry
inferredcites →https://doi.org/10.1021/ja034646dopenalex-snapshot
Fluorine-NMR Experiments for High-Throughput Screening: Theoretical Aspects, Practical Considerations, and Range of Applicability
inferredcites →https://doi.org/10.1021/jm00049a008openalex-snapshot
Design and Synthesis of Potent and Highly Selective Thrombin Inhibitors
inferredcites →https://doi.org/10.1021/jm040031vopenalex-snapshot
Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1021/jm200642wopenalex-snapshot
A Small Nonrule of 3 Compatible Fragment Library Provides High Hit Rate of Endothiapepsin Crystal Structures with Various Fragment Chemotypes
inferredcites →https://doi.org/10.1021/jm8000373openalex-snapshot
Recent Developments in Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1021/jm991174yopenalex-snapshot
Biosensor Analysis of the Interaction between Immobilized Human Serum Albumin and Drug Compounds for Prediction of Human Serum Albumin Binding Levels
inferredcites →https://doi.org/10.1021/ml900002kopenalex-snapshot
Fragment Screening by Surface Plasmon Resonance
inferredcites →https://doi.org/10.1023/a:1013302231549openalex-snapshot
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
inferredcites →https://doi.org/10.1038/nbt0596-595openalex-snapshot
Locating and characterizing binding sites on proteins
inferredcites →https://doi.org/10.1038/nprot.2013.130openalex-snapshot
A three-stage biophysical screening cascade for fragment-based drug discovery
inferredcites →https://doi.org/10.1038/nrd2083openalex-snapshot
Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes
inferredcites →https://doi.org/10.1038/nrd706openalex-snapshot
High-throughput crystallography for lead discovery in drug design
inferredcites →https://doi.org/10.1073/pnas.1304045110openalex-snapshot
Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery
inferredcites →https://doi.org/10.1089/adt.2011.0380openalex-snapshot
Molecular Interaction Studies Using Microscale Thermophoresis
inferredcites →https://doi.org/10.1126/science.274.5292.1531openalex-snapshot
Discovering High-Affinity Ligands for Proteins: SAR by NMR
inferredcites →https://doi.org/10.1177/108705710100600609openalex-snapshot
High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery
inferredcites →https://doi.org/10.1177/1087057112465979openalex-snapshot
Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?
inferredcites →https://doi.org/10.2174/1568026054637700openalex-snapshot
Library Design for Fragment Based Screening
inferredcites →https://doi.org/10.2174/156802607782341073openalex-snapshot
SPR-based Fragment Screening: Advantages and Applications
inferredcites →https://doi.org/10.3168/jds.s0022-0302(70)86194-xopenalex-snapshot
Endothia parasitica Protease. Parameters Affecting Stability of the Rennin-like Enzyme
inferredcites →https://doi.org/10.4155/fmc.09.141openalex-snapshot
Native Ms: An ‘Esi’ Way to Support Structure- and Fragment-Based Drug Discovery

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/9781119099512.ch1openalex-snapshot
Introduction
inferred← citeshttps://doi.org/10.1002/ange.201509843openalex-snapshot
Strukturbasierte Entwicklung einer Affinitätssonde für Sirtuin 2
inferred← citeshttps://doi.org/10.1002/ange.201609824openalex-snapshot
Falsch‐positiver Treffer im Fragment‐basierten Wirkstoffdesign: Lass Dich nicht auf die falsche Fährte locken!
inferred← citeshttps://doi.org/10.1002/ange.201702888openalex-snapshot
Fragment Screening against the EthR–DNA Interaction by Native Mass Spectrometry
inferred← citeshttps://doi.org/10.1002/anie.201509843openalex-snapshot
Structure‐Based Development of an Affinity Probe for Sirtuin 2
inferred← citeshttps://doi.org/10.1002/anie.201609824openalex-snapshot
A False‐Positive Screening Hit in Fragment‐Based Lead Discovery: Watch out for the Red Herring
inferred← citeshttps://doi.org/10.1002/anie.201702888openalex-snapshot
Fragment Screening against the EthR–DNA Interaction by Native Mass Spectrometry
inferred← citeshttps://doi.org/10.1002/appl.202400192openalex-snapshot
Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural Enablement
inferred← citeshttps://doi.org/10.1002/ardp.202300612openalex-snapshot
Extracting binding energies and binding modes from biomolecular simulations of fragment binding to endothiapepsin
inferred← citeshttps://doi.org/10.1002/ardp.202400061openalex-snapshot
Assessment of fragment docking and scoring with the endothiapepsin model system
inferred← citeshttps://doi.org/10.1002/cmdc.201700177openalex-snapshot
Critical Evaluation of Native Electrospray Ionization Mass Spectrometry for Fragment‐Based Screening
inferred← citeshttps://doi.org/10.1002/cmdc.201900604openalex-snapshot
Fragments as Novel Starting Points for tRNA‐Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies
inferred← citeshttps://doi.org/10.1007/978-1-0716-1665-9_6openalex-snapshot
MST and TRIC Technology to Reliably Study PROTAC Binary and Ternary Binding in Drug Development
inferred← citeshttps://doi.org/10.1016/b978-0-08-099420-8.00003-1openalex-snapshot
Step IIIa: Biological Hit Discovery Through High-Throughput Screening (HTS): Random Approaches and Rational Design
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12313-3openalex-snapshot
Hit and Lead Generation Strategies
inferred← citeshttps://doi.org/10.1016/j.aca.2020.03.062openalex-snapshot
Miniaturized weak affinity chromatography for ligand identification of nanodiscs-embedded G-protein coupled receptors
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.10.003openalex-snapshot
Targeting tuberculosis using structure-guided fragment-based drug design
inferred← citeshttps://doi.org/10.1016/j.jcou.2021.101695openalex-snapshot
Synthesis of 1,3-oxazine-2,4-diones by DBU-catalyzed incorporation of carbon dioxide into 3-ynamides
inferred← citeshttps://doi.org/10.1016/j.pbiomolbio.2020.10.005openalex-snapshot
Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2016.07.003openalex-snapshot
The ways and means of fragment-based drug design
inferred← citeshttps://doi.org/10.1016/j.str.2016.06.010openalex-snapshot
High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits
inferred← citeshttps://doi.org/10.1021/acs.analchem.1c03130openalex-snapshot
Bioaffinity Screening with a Rapid and Sample-Efficient Autosampler for Native Electrospray Ionization Mass Spectrometry
inferred← citeshttps://doi.org/10.1021/acs.analchem.7b05349openalex-snapshot
Charge-State-Dependent Variation of Signal Intensity Ratio between Unbound Protein and Protein–Ligand Complex in Electrospray Ionization Mass Spectrometry: The Role of Solvent-Accessible Surface Area
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00556openalex-snapshot
Assessment of the Fragment Docking Program SEED
inferred← citeshttps://doi.org/10.1021/acs.jctc.9b00069openalex-snapshot
Fragment Binding Pose Predictions Using Unbiased Simulations and Markov-State Models
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c02094openalex-snapshot
Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00830openalex-snapshot
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01607openalex-snapshot
Structurally Diverse Mitochondrial Branched Chain Aminotransferase (BCATm) Leads with Varying Binding Modes Identified by Fragment Screening
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01940openalex-snapshot
Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00197openalex-snapshot
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00645openalex-snapshot
Experimental Active-Site Mapping by Fragments: Hot Spots Remote from the Catalytic Center of Endothiapepsin
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01195openalex-snapshot
Active Site Mapping of an Aspartic Protease by Multiple Fragment Crystal Structures: Versatile Warheads To Address a Catalytic Dyad
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.7b00606openalex-snapshot
Identification of a New Zinc Binding Chemotype by Fragment Screening
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b01492openalex-snapshot
Developing Inhibitors of the p47phox–p22phox Protein–Protein Interaction by Fragment-Based Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.3c01161openalex-snapshot
Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence
inferred← citeshttps://doi.org/10.1021/acschembio.5b01034openalex-snapshot
Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study
inferred← citeshttps://doi.org/10.1021/acschembio.6b00730openalex-snapshot
Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to 1H CPMG Ligand-Observed NMR
inferred← citeshttps://doi.org/10.1021/acschembio.8b00875openalex-snapshot
CellFy: A Cell-Based Fragment Screen against C-Type Lectins
inferred← citeshttps://doi.org/10.1038/nrd.2016.109openalex-snapshot
Twenty years on: the impact of fragments on drug discovery
inferred← citeshttps://doi.org/10.1038/nrd.2016.123openalex-snapshot
Biophysics in drug discovery: impact, challenges and opportunities
inferred← citeshttps://doi.org/10.1038/s41467-023-41420-5openalex-snapshot
Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1
inferred← citeshttps://doi.org/10.1038/s41467-025-63602-zopenalex-snapshot
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors
inferred← citeshttps://doi.org/10.1038/s41467-026-68941-zopenalex-snapshot
Developments and challenges in hit progression within fragment-based drug discovery
inferred← citeshttps://doi.org/10.1038/s41598-018-37072-xopenalex-snapshot
Isothermal Analysis of ThermoFluor Data can readily provide Quantitative Binding Affinities
inferred← citeshttps://doi.org/10.1038/s41598-020-80588-4openalex-snapshot
Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery
inferred← citeshttps://doi.org/10.1038/s41598-022-25464-zopenalex-snapshot
A novel small molecule inhibitor of human Drp1
inferred← citeshttps://doi.org/10.1038/s41598-025-23858-3openalex-snapshot
Discovery of first-in-class inhibitors of the TRF1:TIN2 protein:protein interaction by fragment screening
inferred← citeshttps://doi.org/10.1038/s42004-025-01574-3openalex-snapshot
Crystallographic fragment screening reveals ligand hotspots in TRIM21 PRY-SPRY domain
inferred← citeshttps://doi.org/10.1039/9781788018982-00188openalex-snapshot
Fragment-based Ligand Discovery (FBLD)
inferred← citeshttps://doi.org/10.1039/c5cc10457bopenalex-snapshot
Chemical fragment arrays for rapid druggability assessment
inferred← citeshttps://doi.org/10.1039/d4md00273copenalex-snapshot
Fragment-based drug discovery campaigns guided by native mass spectrometry
inferred← citeshttps://doi.org/10.1039/d5md00617aopenalex-snapshot
Toward routine utilisation of native mass spectrometry as an enabler of contemporary drug development
inferred← citeshttps://doi.org/10.1093/jb/mvac020openalex-snapshot
Fragment-Based Drug Discovery forTrypanosoma bruceiGlycosylphosphatidylinositol-Specific Phospholipase C through Biochemical and WaterLOGSY-NMR Methods
inferred← citeshttps://doi.org/10.1101/2022.05.14.491971openalex-snapshot
Structural-guided fragment-based drug discovery applied to antitoxin, MAB3862 opens a new possibility of exploring the Toxin and Antitoxin for antibiotics
inferred← citeshttps://doi.org/10.1101/2024.04.29.591502openalex-snapshot
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
inferred← citeshttps://doi.org/10.1107/s2053230x16004623openalex-snapshot
Structures of endothiapepsin–fragment complexes from crystallographic fragment screening using a novel, diverse and affordable 96-compound fragment library
inferred← citeshttps://doi.org/10.1111/bph.70126openalex-snapshot
Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling
inferred← citeshttps://doi.org/10.1177/2472555217744728openalex-snapshot
Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective
inferred← citeshttps://doi.org/10.15406/mojbb.2017.04.00062openalex-snapshot
Using Fragment Based Drug Discovery to Target Epigenetic Regulators in Cancer
inferred← citeshttps://doi.org/10.3390/ijms20123112openalex-snapshot
Targeting Quorum Sensing: High-Throughput Screening to Identify Novel LsrK Inhibitors
inferred← citeshttps://doi.org/10.3390/ijms25074084openalex-snapshot
The Discovery of New Inhibitors of Insulin-Regulated Aminopeptidase by a High-Throughput Screening of 400,000 Drug-like Compounds
inferred← citeshttps://doi.org/10.3390/molecules21080984openalex-snapshot
Native Mass Spectrometry in Fragment-Based Drug Discovery
inferred← citeshttps://doi.org/10.3390/molecules25071760openalex-snapshot
Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA
inferred← citeshttps://doi.org/10.3390/ph15010026openalex-snapshot
Discovery of Cofactor Competitive Inhibitors against the Human Methyltransferase Fibrillarin
inferred← citeshttps://doi.org/10.3410/f.735152643.793558062openalex-snapshot
Faculty Opinions recommendation of Isothermal Analysis of ThermoFluor Data can readily provide Quantitative Binding Affinities.
inferred← citeshttps://doi.org/10.47749/t/unicamp.2018.1102653openalex-snapshot
Aplicação da técnica FBDD ¨fragment based drug discovery¨ para a enzima DHFR da via de biossíntese de folatos em Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.5772/66423openalex-snapshot
Going Small: Using Biophysical Screening to Implement Fragment Based Drug Discovery
inferred← citeshttps://doi.org/10.70675/b2626169z07ebz4d3bzb054z793455cd3f0eopenalex-snapshot
Développement d’une nouvelle approche de criblage et de caractérisation d’interactions ligand-protéine membranaire par chromatographie de faible affinité miniaturisée
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.